The Economist asks:
Will the US FDA approve the drug molnupiravir for use to treat COVID-19 before 1 October 2021?
Closed Oct 1, 2021 07:01AM (3 years ago)
Molnupiravir, a drug being developed by Merck and Ridgeback Biotherapeutics, has shown positive results in clinical trials in combatting COVID-19 (Economist, Fox News, Merck). “Compassionate use" and "emergency use" authorizations would count (FDA, FDA).
Confused? Check our FAQ or ask us for help. To learn more about Good Judgment and Superforecasting, click here.
To learn more about how you can become a Superforecaster, see here. For other posts from our Insights blog, click here.
NOTE 3 August 2021: FDA approval for molnupiravir for use in combination with other therapeutics to treat COVID-19 would count.
The question closed "No" with a closing date of 1 October 2021.
See our FAQ to learn about how we resolve questions and how scores are calculated.
| Possible Answer | Correct? | Final Crowd Forecast |
|---|---|---|
| Yes | 0% | |
| No | 100.00% |
Crowd Forecast Profile
| Participation Level | |
|---|---|
| Number of Forecasters | 192 |
| Average for questions older than 6 months: 180 | |
| Number of Forecasts | 596 |
| Average for questions older than 6 months: 526 | |
| Accuracy | |
|---|---|
| Participants in this question vs. all forecasters | average |
